FDA approves new HIV treatment for patients who have limited treatment options

The FDA approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies.

The post FDA approves new HIV treatment for patients who have limited treatment options appeared first on MrTopStep.com.